Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
Abstract
The present specification disclosed a noninvasive transdermal delivery device that relates generally to a handheld mechanical apparatus for noninvasive transdermal administration of gas, small to large water-soluble (hydrophilic) pharmaceutical agents, vitamins, and other therapeutic agents. Components of such delivery devices, methods of producing a substance comprising a supersaturated amount of a dissolved gas, as well as, methods of administering a therapeutic agent using such delivery devices and methods of treating a disease or condition using such delivery devices are also disclosed.
Claims
exact text as granted — not AI-modified1 - 35 . (canceled)
36 . A transdermal delivery device comprising:
a) a housing including i) an external body shell comprising a fluid chamber assembly access cover movably engaged with the external body shell; ii) an interior compartment including an open-ended delivery outlet and a vapor producing assembly compartment; and iii) a cartridge retaining container comprising an external covering shell and an internal cartridge compartment configured to hold a compressed gas cartridge, wherein the cartridge retaining container is detachably engaged with the external body shell; wherein the vapor producing assembly compartment is located in between the open-ended delivery outlet and the cartridge retaining container; and b) a vapor producing assembly including i) a fluid chamber assembly comprising a fluid container and a removable fluid container cap; and ii) a permeation valve configured to reduce the pressure of a gas removed from the compressed gas cartridge and delivered to the fluid chamber assembly; wherein the vapor producing assembly is substantially contained within the vapor producing assembly compartment.
37 . The transdermal delivery device of claim 36 , wherein the external covering shell defines the internal cartridge compartment.
38 . The transdermal delivery device of claim 36 , wherein the device further includes a control switch assembly.
39 . The transdermal delivery device of claim 38 , wherein the control switch assembly is a mechanical switch or an electronic switch.
40 . The transdermal delivery device of claim 36 , wherein the compressed gas cartridge is a 16 g compressed gas cartridge.
41 . The transdermal delivery device of claim 36 , wherein the compressed gas cartridge includes a compressed gas.
42 . The transdermal delivery device of claim 41 , wherein the compressed gas is carbon dioxide.
43 . The transdermal delivery device of claim 36 , wherein the permeation valve is configured to reduce gas pressure to below 40 psi.
44 . The transdermal delivery device of claim 36 , wherein the permeation valve comprises at least one permeable member selected from rubber, cork, textile, porous polymer, densely sintered metal or combinations thereof.
45 . The transdermal delivery device of claim 36 , wherein the fluid container includes water.
46 . A transdermal delivery device comprising
a cylinder containing pressurized carbon dioxide; a permeation valve configured to reduce the pressure of the pressurized carbon dioxide; a chamber configured to supersaturate a liquid in the chamber with carbon dioxide thereby forming a therapeutic vapor; and a treatment chamber configured to deliver the therapeutic vapor to an individual.
47 . A method of producing a substance comprising a supersaturated amount of dissolved gas, the method comprising the steps of:
a) placing the substance in an air-tight container; and b) exposing the substance to carbon dioxide, wherein upon exposure, the carbon dioxide dissolves into the substance in an amount greater than the substance could dissolve at 25° C. and 1 atm.
48 . The method of claim 47 , wherein the substance is a liquid or a colloid.
49 . The method of claim 48 , wherein the colloid is a foam, a liquid, an aerosol, an emulsion, a gel, or a sol.
50 . The method of claim 48 , wherein the liquid is water at pH 4.
51 . The method of claim 47 , wherein dissolved carbon dioxide is produced at a concentration of at least 600 ppm.Join the waitlist — get patent alerts
Track US2019091454A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.